Cargando…
A nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer
BACKGROUND: Immune checkpoint inhibitor (ICI) therapy is an emerging type of treatment for lung cancer (LC). However, hyperprogressive disease (HPD) has been observed in patients treated with ICIs that lacks a prognostic prediction model. There is an urgent need for a simple and easily implementable...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073744/ https://www.ncbi.nlm.nih.gov/pubmed/35529793 http://dx.doi.org/10.21037/tlcr-22-171 |